Comment on "Insights of Fabry disease: Expert consensus approach for screening, diagnosis, and multidisciplinary management in chronic kidney disease" [0.03%]
关于法布雷病的专家共识:慢性肾脏疾病患者筛查、诊断和多学科管理的见解评论
K Suresh Babu,S Sasidharan,V Poongodi et al.
K Suresh Babu et al.
Comment on "Real-world time-trend impact of rib fracture fixation on patients with multiple trauma using propensity score and ARIMA approaches" [0.03%]
关于“使用倾向性评分和ARIMA方法分析肋骨骨折固定对多发伤患者现实世界时间趋势影响”的评论
Ankit Kumar Garg,Swasti Keshri
Ankit Kumar Garg
Comment on "Utilization and stakeholder perspectives on traditional Chinese medicine in Taiwan's integrated home-based medical care: a mixed-methods study" [0.03%]
台湾整合居家医疗照顾中中医药的运用及其利害关系人的视角:一种混合方法研究的评论
Bhumikaben Gajendrasinh Thakor,Surbhi Damar,Ghutiya Jyotiben Rameshbhai
Bhumikaben Gajendrasinh Thakor
Comment on "Comparative performance of machine learning and conventional scoring systems for neuroprognostication in out-of-hospital cardiac arrest survivors" [0.03%]
关于“机器学习与传统评分系统在外科心脏复苏幸存者神经预后中的比较表现”的评论
V Vasudha Rani,G Vasavi,K V Siva Prasad Reddy
V Vasudha Rani
Response to comment on "Real-world time-trend impact of rib fracture fixation on patients with multiple trauma using propensity score and ARIMA approaches" [0.03%]
关于“使用倾向性评分和ARIMA方法分析肋骨骨折固定对多发伤患者现实世界趋势影响”的评论回复
Wen-Ruei Tang,Chih-Jung Wang,Yi-Ting Yen et al.
Wen-Ruei Tang et al.
Multi-vendor, multi-field strength validation of MRI-Proton density fat fraction for fat quantification: A standardized phantom study [0.03%]
多供应商、多场强MRI质子密度脂肪分数脂肪定量的多机构研究:基于标准化体素内谱分割方法的磷脂量化标准模型研究
Kuang-Chen Yen,Po-Chin Liang,Yueh-Hsun Lu et al.
Kuang-Chen Yen et al.
Background/purpose: This study aimed to validate the accuracy and consistency of Magnetic Resonance Imaging Proton Density Fat Fraction (MRI-PDFF) across systems from three major vendors at two field strengths. ...
Comment on: The predict value of lymph node status pre-operation by ultrasound, mammography and MRI in early breast cancer [0.03%]
论原发性乳腺癌术前分期中不同影像学检查对淋巴结状态预测价值的差异
Huaixuan Jiang,Chun Zhang
Huaixuan Jiang
Vascular frailty definitions: Associations with low hand grip strength and multimorbidity in older adults [0.03%]
血管性脆弱的定义:与老年人低握力和多病共存的关系
Le Zhang,Xin Wei,Ping Hou
Le Zhang
Daratumumab, lenalidomide, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma: A real-world propensity score-matched study [0.03%]
达雷妥尤单抗、来那度胺和地塞米松对比达雷妥尤单抗、硼替佐米和地塞米松治疗复发和难治多发性骨髓瘤的回顾性倾向评分匹配研究
Cheng-Hsien Lin,Po-Wei Liao,Chieh-Lin Jerry Teng et al.
Cheng-Hsien Lin et al.
Aims: Multiple myeloma (MM) is an incurable plasma cell malignancy. Daratumumab-lenalidomide-dexamethasone (DRd) and daratumumab-bortezomib-dexamethasone (DVd) are widely used in relapsed/refractory MM (RRMM) treatment. A...